A molecular gate which controls unnatural ATP analogue recognition by the tyrosine kinase v-Src.

Engineered proteins with specificity for unnatural substrates or ligands are useful tools for studying or manipulating complex biological systems. We have engineered the prototypical tyrosine kinase v-Src to accept an unnatural ATP analogue N6-(benzyl) ATP in order to identify v-Src's direct cellular substrates. Here we have used molecular modeling to analyze the binding mode of N6-(benzyl) ATP. Based on this modeling we proposed that a new ATP analogue (N6-(2-phenethyl) ATP might be a better substrate than N6-(benzyl) ATP for the I338G mutant of v-Src. In fact the newly proposed analogue (N6-(2-phenethyl) ATP is a somewhat improved substrate for the engineered kinase (kcat = 0.6 min-1, KM = 8 microM). We also synthesized and screened three analogues of N6-(benzyl) ATP: N6-(2-methylbenzyl), ATP N6-(3-methylbenzyl), and ATP N6-(4-methylbenzyl) ATP to further probe the dimensions and shape of the introduced pocket. Results from screening newly synthesized ATP analogues agreed well with our modeling predictions. We conclude that rather than engineering a 'new' pocket by mutation of Ile 338 in v-Src to the smaller Ala or Gly residues, the I338G and I338A mutants possess a 'path' for the N6 substituent on ATP to gain access to an existing pocket in the ATP binding site. We expect to be able to extend the engineering of v-Src's ATP specificity to other kinase families based on our understanding of the binding modes of ATP analogues to engineered kinases.

[1]  K. Shokat,et al.  Engineering Src family protein kinases with unnatural nucleotide specificity. , 1998, Chemistry & biology.

[2]  D. Baltimore,et al.  Modular binding domains in signal transduction proteins , 1995, Cell.

[3]  D. A. Dougherty,et al.  Site-specific, photochemical proteolysis applied to ion channels in vivo. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Simon,et al.  Characterization of a Goα Mutant That Binds Xanthine Nucleotides* , 1997, The Journal of Biological Chemistry.

[5]  Nguyen-Huu Xuong,et al.  Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with magnesium-ATP and peptide inhibitor , 1993 .

[6]  D. Holt,et al.  A versatile synthetic dimerizer for the regulation of protein-protein interactions. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  John Kuriyan,et al.  Crystal structure of the Src family tyrosine kinase Hck , 1997, Nature.

[8]  P G Schultz,et al.  A general method for site-specific incorporation of unnatural amino acids into proteins. , 1989, Science.

[9]  T. Hunter,et al.  The protein kinases of budding yeast: six score and more. , 1997, Trends in biochemical sciences.

[10]  Michael J. Eck,et al.  Three-dimensional structure of the tyrosine kinase c-Src , 1997, Nature.

[11]  H. Lester,et al.  An Engineered Tetrahymena tRNAGln for in Vivo Incorporation of Unnatural Amino Acids into Proteins by Nonsense Suppression* , 1996, The Journal of Biological Chemistry.

[12]  T. Hunter.  Tyrosine phosphorylation: past, present and future. , 1996, Biochemical Society Transactions.

[13]  S. Schreiber,et al.  Rational Design of Orthogonal Receptor - Ligand Combinations** , 1995 .

[14]  S. Schreiber,et al.  Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T. Pawson,et al.  Signaling through scaffold, anchoring, and adaptor proteins. , 1997, Science.

[16]  K. Kikugawa,et al.  Platelet aggregation inhibitors. 4. N 6 -substituted adenosines. , 1973, Journal of medicinal chemistry.

[17]  P. Schultz,et al.  Characterization of an 'orthogonal' suppressor tRNA derived from E. coli tRNA2(Gln). , 1997, Chemistry & biology.

[18]  Kornelia Polyak,et al.  Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex , 1995, Nature.

[19]  Hiroto Yamaguchi,et al.  Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation , 1996, Nature.

[20]  K. Shokat,et al.  Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[21]  P. Schultz,et al.  Site-directed mutagenesis with an expanded genetic code. , 1995, Annual review of biophysics and biomolecular structure.

[22]  S. Schreiber,et al.  Cell-Specific Calcineurin Inhibition by a Modified Cyclosporin , 1997 .

[23]  A. Weijland,et al.  Toward a model for the interaction between elongation factor Tu and the ribosome. , 1993, Science.

[24]  P. Schultz,et al.  Engineering a tRNA and aminoacyl-tRNA synthetase for the site-specific incorporation of unnatural amino acids into proteins in vivo. , 1997, Proceedings of the National Academy of Sciences of the United States of America.